The largest database of trusted experimental protocols
> Living Beings > Population Group > Black People

Black People

Black People: A broad term referring to individuals or populations with African ancestral origins, whose skin pigmentation can range from very dark brown to black.
Includes groups such as African Americans, Africans, and other populations with similar phenotypic and sociocultural characteristics.
Exploring the unique health and socioeconomic challenges faced by Black communities can lead to improved understanding and more equitable healthcare outcomes.

Most cited protocols related to «Black People»

Our goal was to compare the current CKD-EPI eGFRcr, eGFRcys, and eGFRcr-cys equations with equations developed with the use of two new approaches for GFR estimation that do not involve race.5 (link),9 (link) As we described previously, the current approach to the development of CKD-EPI equations has been to model eGFR with the use of least-squares linear regression to relate log-transformed measured GFR to log-transformed filtration markers, age, sex, and race with separate slopes for higher as compared with lower levels of creatinine and cystatin C.5 (link),9 (link) Race is an explanatory variable in the current eGFRcr and eGFRcr-cys equations but not in the current eGFRcys equation.
The first set of new equations uses the same coefficients for the intercept, age, sex and creatinine level as in the current eGFRcr and eGFRcr-cys equations but removes the Black race coefficient in computing eGFR, thereby assigning the eGFRcr and eGFRcr-cys values for non-Black persons to Black persons. For the second set of new equations, we fit new models using eGFRcr and eGFRcr-cys by means of the same regression function as the current equations but without inclusion of race as an explanatory variable. In total, we evaluated seven equations (three current and four new equations). Because all equations were developed by the CKD-EPI research group, we refer to them only by the filtration marker or markers (creatinine [eGFRcr], cystatin C [eGFRcys], or creatinine–cystatin C [eGFRcr-cys]) and the demographic factors (age, sex, and race [ASR] or age and sex [AS]) that were used in their development. We use the term non-Black (NB) to refer to ASR equations that were fit with a race term but in which the Black race coefficient was removed for computation of eGFR. Additional details are provided in the Methods section in the Supplementary Appendix.
In the development data sets, we assessed bias (systematic error) as the difference between measured GFR and eGFR and assessed model fit using root-mean-square error.5 (link),9 (link) In the validation data set, we assessed accuracy overall and within race groups as bias, percentage of estimates less than 30% different from measured GFR (P30, with 1−P30 corresponding to large errors that may be clinically significant), and agreement of eGFR with measured GFR categories using guideline-recommended GFR stages (<30, 30 to 44, 45 to 59, 60 to 89, and >90 ml per minute per 1.73 m2 of body-surface area).8 A P30 value of 80 to 90% is considered to be acceptable for GFR evaluation in many circumstances, and a P30 value of 90% or higher is preferred; these values correspond to approximately 60 to 70% agreement and more than 70% agreement of eGFR with measured GFR in GFR categories, respectively.5 (link),8 ,9 (link) We also focused on differential bias (systematic differences) between race groups because it could lead to systematic differences in treatment for the same measured GFR level. Confidence intervals for bias were calculated by means of bootstrap methods. We assessed accuracy in subgroups according to eGFR (as defined above), age (<40, 40 to 65, and >65 years), sex, and body-mass index (BMI, the weight in kilograms divided by the square of the height in meters: ≤25, 25 to <30, and ≥30).
In sensitivity analyses, we weighted the proportion of Black participants in the development data set from 0 to 100% to evaluate the effect on accuracy. In the validation data set, we calibrated measured GFR to account for differences between measurement methods as compared with the development data sets,5 (link),9 (link),23 (link) and we compared equations that were developed by other research groups to estimate GFR in adults.24 (link)–28 (link)
Publication 2021
Adult Black People Body Surface Area Creatinine EGFR protein, human Filtration Hypersensitivity Index, Body Mass Plant Roots Post-gamma-Globulin Racial Groups
Pilot studies conducted during the planning stages for BT10 in 1989 and 1990 examined several issues in an attempt to seek clarity on the anticipated numbers of children who could be enrolled into a cohort and the potential for their follow-up. These included: the monthly birth rate and seasonality of births in Soweto-Johannesburg, the scope and accuracy of routinely collected health services and local ordinance data, the feasibility and logistics of follow-up, and estimates of sample losses, at least over the short-term.3 (link) These studies indicated, amongst others, that an average of 2680 children were born each month within the defined study area; random patterns of births pertained amongst all groups of people, except for October, during which a significant increase in births occurred;23 approximately 16% of hospital deliveries were not recorded in routine delivery ward records because the births were directed through surgery and other specialised treatment services; routinely collected data was not suitable, without modification, for translation into research information because of differences in formats across service centres, lack of standardisation of measurements, unreliability, and incompleteness.24 ,25 (link) The results of the pilot studies were used to operationalise procedures for the enrolment of the birth cohort.
The pilot studies also indicated that 20% of deliveries were immediately lost to follow-up because mothers could not be found after delivery at the addresses they had given or because the addresses they had recorded were patently false. In discussion with health service personnel and as confirmed on more intensive follow-up during the first year, it was concluded that this group of people consisted of non-resident women who planned to deliver their babies in Soweto-Johannesburg for personal or social reasons, and that they were either highly mobile within the area, or that they gave false addresses when admitted to a delivery centre. Some of the reasons why women from rural and peri-urban areas came to Johannesburg-Soweto to deliver their babies were, at the time, that they continued to believe that the place of birth of their child determined access to work as was the case under Apartheid laws to control the movement and employment of black people; they assumed that the health services in the city were superior to those in rural areas, and they came to the urban areas where their migrant husbands were working to receive financial and social support during their confinement. These women returned to their customary places of residence, usually in rural areas, soon after delivery and, for this reason, could not be considered part of a residential birth cohort in Soweto-Johannesburg.
Of the remaining deliveries, 80% were traceable 9 months after their birth. The conclusion from the pilot studies was that 64% of all births, and 80% of the resident birth cohort, were likely to be traceable for at least a year. At the time of the pilot studies, the BT10 scientific team concluded that BT10, as planned, could satisfy the basic conditions of a prospective longitudinal study – that ‘the success of a prospective birth cohort depended on an initial sample size large enough, and representative of the population, to (i) reflect a sufficient range of exposures, (ii) allow for generalisability of findings, and (iii) provide sufficient subjects who have stayed in the study throughout the period of investigation, a group known as the core sample’.4 (link), p. 449 In other longitudinal studies, eventual cohort sizes of around 1500 have been regarded as sufficient.15 In the light of experience gained in the course of the pilot studies, a plan for the recruitment and retention of cases was developed, and this plan has been continually refined as the study has progressed.
Publication 2004
Birth Cohort Black People Child Childbirth Health Personnel Husband Infant Light Migrants Mothers Movement Obstetric Delivery Operative Surgical Procedures Retention (Psychology) Woman
Wave 1 of the PATH Study included 45,971 adults and youths in the United States 12 years of age or older; data were collected from September 12, 2013, through December 15, 2014. This article reports national estimates from 32,320 adult participants (≥18 years of age) and 13,651 youth participants (12 to 17 years of age). Parent interviews were also conducted with one parent of 13,589 of the youth participants (99.5%). The parent interview collected information about the youth that was deemed to be more reliable when obtained from a parent (e.g., certain health information), as well as contextual information about the household and the parent’s own use of tobacco. Adult and youth data were collected with the use of an audio computer-assisted self-interview (ACASI), available in English and Spanish.
Address-based, area-probability sampling was used for recruitment; an in-person household screener selected youths and adults. Adult tobacco users, young adults (18 to 24 years of age), and black persons were oversampled relative to population proportions. Up to 2 youths per household were sampled unless a household included multiple births, in which case additional youths could be selected. Weighting procedures adjusted for oversampling and nonresponse. The weights were further adjusted so that the sums of the weights matched independent population totals for standard demographic groups; these totals were based on U.S. Census Bureau data. (For details on youth sampling and weighting procedures, see the Supplementary Appendix, available with the full text of this article at NEJM.org.) Combined with the use of a probability sample, the weighted data allow estimates produced by the PATH Study to be representative of the civilian, noninstitutionalized U.S. population. The weighted response rate for the household screener was 54.0%. Among screened households, the overall weighted response rate was 74.0% for the adult interview and 78.4% for the youth interview. A nonresponse bias analysis for Wave 1 can be found at http://doi.org/10.3886/ICPSR36231.
The PATH Study implemented numerous procedures to protect respondents’ privacy and confidentiality, including obtaining written informed consent from adults and written assent from youths; requiring all staff to be certified in data security, confidentiality, and privacy issues and procedures; requiring staff to sign a pledge of confidentiality; storing and transmitting data with the use of advanced data encryption; and identifying survey data and biospecimens with the use of randomly assigned identification numbers and storing identifying information in separate, secure files. Further details regarding the PATH Study design and methods are reported by Hyland et al.29 The study was conducted by Westat, a contract research organization, and approved by its institutional review board.
Publication 2017
Adult Black People Ethics Committees, Research Hispanic or Latino Households Multiple Birth Offspring Parent Tobacco Products Young Adult Youth
Calculation of incidence was conducted at CHBH, the only site for which population denominator data were available. This hospital is the only public hospital serving a community of ≈1.3 million black African persons in 2011, of whom ≈10% have private medical insurance (21 ). Most (>80%) uninsured persons and ≈10% of insured persons seek care at public hospitals; consequently, most persons requiring hospitalization from this community are admitted to CHBH. We estimated the incidence of influenza hospitalizations per 100,000 persons by using the number of acute LRTI hospitalizations for which the patient tested positive for influenza virus, adjusting for nonenrollment (i.e., refusal to participate, nonenrollment during weekends, nonenrollment in 3 of 5 adult wards) by age groups and HIV status divided by the midyear total population estimates (22 ) for each year, multiplied by 100,000. HIV prevalence in the study population was estimated from the projections of the Actuarial Society of South Africa AIDS and Demographic model (3 ). We assumed that the HIV prevalence by age group and influenza subtype among patients not tested for HIV was the same as that among those tested. For 14 patients for whom influenza A virus subtyping was not performed, we imputed the influenza subtype on the basis of date of specimen collection and circulating influenza subtypes.
CIs for incidence estimates were calculated by using Poisson distribution. Age-specific and overall age-adjusted risk of influenza hospitalization in HIV-infected and -uninfected persons was determined by using log-binomial regression. To explore the possible effect of missing data on estimates of HIV-specific incidence, a sensitivity analysis was conducted in which all cases not tested for HIV were assumed to be HIV uninfected.
Full text: Click here
Publication 2013
Acquired Immunodeficiency Syndrome Adult Age Groups Black People Hospitalization Hypersensitivity Influenza A virus Negroid Races Orthomyxoviridae Patients Specimen Collection Virus Vaccine, Influenza
The sample for the present study included 3024 children 8 to 15 years of age who were evaluated in person at the mobile examination centers of the 2001–2004 NHANES, a nationally representative probability sample of noninstitutionalized US civilians. The NHANES used a complex, stratified, multistage, probability cluster design that oversampled low-income persons, adolescents 12 to 19 years of age, persons >60 years of age, black persons, and Mexican American persons. The response rates for the youth sample ranged from 79.2% to 92.3%, depending on the disorder and the source of information. There were no significant differences in demographic characteristics between participants and nonparticipants. Additional details of the NHANES methods are available elsewhere.
Publication 2009
Adolescent Black People Child Mexican Americans Youth

Most recents protocols related to «Black People»

We collected and categorized covariates such as age (≤ 60 years and > 60 years), sex (male/female), race (non-Hispanic white people, non-Hispanic Black people, Mexican Americans, etc.), educational level (less than grade 9, 9 − 11 grade/graduated from high school or equivalent and college graduated or above), marriage (unmarried, married, separated, divorced, widowed and those living with partner/others), family income, smoking and drinking status. The smoking status was classified into the following: Never smoked (< 100 cigarettes/session), previously smoked (> 100 cigarettes/session, currently not smoking) and current smoker (> 100 cigarettes/session, either on some days or every day) [15 (link)]. Drinking status was categorized as non-drinkers (< 12 drinks in life), ever drinking in the last year (alcohol or 12 drinks in life, currently not drinking), mild/moderate drinkers (over the past year: females, once/day or less; males, twice/day or less), heavy drinkers (over the past year: females, more than once/day; males, > twice/day) [16 (link)]. Medical history and medication use were collected via family interviews and mobile examination centers using standardized questionnaires. The specific details for collecting these covariates can be obtained from the NHANES Laboratory/Medical Technician Procedure Manual [13 ].
Full text: Click here
Publication 2023
Alcoholic Intoxication Alcohols Black People Females Hispanics Males Medical Laboratory Technicians Mexican Americans Pharmaceutical Preparations White Person Woman
The possible effects of the following confounders were assessed: age (continuous), sex (male and female), race (Mexican American, other Hispanic, non-Hispanic white persons, non-Hispanic black persons, and non-Hispanic American), marital status (married/living with a partner, widowed/divorced/separated, and unmarried), education level (less than 9th grade, 9–11th grade, high school graduate/GED or equivalent, some college or a degree, and college graduate or above), BMI (continuous), hypertension (yes and no), and diabetes (yes, borderline, and no).
Full text: Click here
Publication 2023
Black People Diabetes Mellitus Females High Blood Pressures Hispanic Americans Hispanics Males Mexican Americans White Person

Protocol full text hidden due to copyright restrictions

Open the protocol to access the free full text link

Publication 2023
Black People COVID 19 Discrimination, Psychology Intersectional Framework Lens, Crystalline Obstetric Labor Perinatal Care

Protocol full text hidden due to copyright restrictions

Open the protocol to access the free full text link

Publication 2023
Asian Americans Black or African American Black People Care, Prenatal Child Childbirth Children's Health COVID 19 Ethnicity Gender Identity Healthy Volunteers Hispanic or Latino Households Infant Infant Health Services Latinos Negroes Pacific Islander Americans Pregnancy Premature Birth Student Vision
Estimated 10-year ASCVD risk was evaluated using the Pooled Cohort Equations (PCE) model [14 (link),15 (link)]. The PCE model was used to express ASCVD risk in a continuous percentage. The estimated 10-year absolute risk of ASCVD was set to be characterized by death due to coronary heart disease, nonfatal myocardial infarction or fatal or nonfatal stroke over a 10-year period in participants free of established CV diseases. The PCE allowed for the derivation of sex- and race-specific estimates of the 10-year risk for ASCVD for adults aged 40 to 79 years. Parameters included in the PCE were age, gender, Black people, tobacco smoking, total and high-density lipoprotein cholesterol, treated or untreated systolic blood pressure, and diabetes. A PCE score of 7.5% or greater indicated that a participant was at a high ASCVD risk, and participants with a PCE score of less than 7.5% were considered at low risk [19 (link),20 (link)].
Full text: Click here
Publication 2023
Adult Black People Cardiovascular Diseases Cerebrovascular Accident Diabetes Mellitus Gender Heart Disease, Coronary High Density Lipoprotein Cholesterol Myocardial Infarction Systolic Pressure

Top products related to «Black People»

SocINDEX is a comprehensive database that provides access to the full text of scholarly journals, books, and other publications in the field of sociology. It covers a wide range of topics related to the study of human society and social behavior. The database is designed to support research and analysis in the social sciences.
APA PsycINFO is a comprehensive database providing access to psychological literature from the 1800s to the present. It covers a wide range of topics related to psychology, including behavioral sciences, mental processes, and more. The database includes journal articles, books, chapters, and dissertations.
Sourced in United States, Austria, Japan, Cameroon, Germany, United Kingdom, Canada, Belgium, Israel, Denmark, Australia, New Caledonia, France, Argentina, Sweden, Ireland, India
SAS version 9.4 is a statistical software package. It provides tools for data management, analysis, and reporting. The software is designed to help users extract insights from data and make informed decisions.
Sourced in United States
Stata is a statistical software package designed for data analysis, visualization, and modeling. Version 16 of Stata provides a comprehensive set of tools and features for a wide range of statistical techniques, including regression analysis, time series analysis, survey data analysis, and much more. Stata 16 is available for Windows, macOS, and Linux operating systems.
Sourced in United States, Japan, Austria, Germany, United Kingdom, France, Cameroon, Denmark, Israel, Sweden, Belgium, Italy, China, New Zealand, India, Brazil, Canada
SAS software is a comprehensive analytical platform designed for data management, statistical analysis, and business intelligence. It provides a suite of tools and applications for collecting, processing, analyzing, and visualizing data from various sources. SAS software is widely used across industries for its robust data handling capabilities, advanced statistical modeling, and reporting functionalities.
Sourced in United States, Austria, Japan, Belgium, Brazil, United Kingdom, Cameroon
SAS software version 9.4 is a comprehensive data analysis and management solution. It provides advanced statistical and analytical capabilities for organizations to manage, analyze, and report on their data. The software includes a range of tools and features to support various data-driven tasks, such as data manipulation, statistical modeling, and predictive analytics.
Sourced in United States, Austria, United Kingdom, Cameroon, Belgium, Israel, Japan, Australia, France, Germany
SAS v9.4 is a software product developed by SAS Institute. It is a comprehensive data analysis and statistical software suite. The core function of SAS v9.4 is to provide users with tools for data management, analysis, and reporting.

More about "Black People"

African Americans, Africans, Black Communities, Black Populations, Black Researchers, African Ancestral Origins, Dark-Skinned Individuals, Ethnic Minorities, Marginalized Groups, Underrepresented Populations, Racial Disparities, Social Determinants of Health, Socioeconomic Challenges, Health Equity, Inclusive Research, Reproducibility, Accuracy, Scientific Protocols, AI-Driven Comparisons, Literature Reviews, Pre-Prints, Patents, Research Tools, SocINDEX, APA PyscINFO, SAS version 9.4, Stata statistical software version 16, SAS software, SAS software version 9.4, SAS v9.4.
Black individuals and communities face unique health and socioeconomic challenges due to systemic inequities and barriers to accessing quality healthcare.
Exploring these disparities can lead to more equitable and inclusive healthcare outcomes.
PubCompare.ai is an AI-powered tool that empowers Black researchers to enhance the reproducibility and accuracy of their scientific protocols by comparing options from literature, pre-prints, and patents.
By leveraging this innovative technology, Black researchers can identify the best protocols and products to boost their scientific outcomes and advance their fields of study.
Whether you're conducting research, developing new treatments, or addressing social determinants of health, PubCompare.ai can be a valuable resource in your efforts to promote greater diversity, equity, and inclusion in the scientific community.